Maine LD 289: An Act To Amend the Health Plan Improvement Law Regarding Prescription Drug Step Therapy

LD 289 (subjects: INSURANCE , HEALTH )

Official bill page at mainelegislature.org: http://www.mainelegislature.org/legis/bills/display_ps.asp?ld=289&PID=1456&snum=127


Sponsors | Actions | Bill Text & Amendments | Patterns of Support


Sponsors

Principal Sponsor: Sen. Kimberley Rosen of Hancock: (R – District 8) — e-mail | Facebook

2 Cosponsors:

Actions

Chamber

Action
2/5/2015 Senate Committee on INSURANCE AND FINANCIAL SERVICES
suggested and ordered printed
On motion by Senator MASON of Androscoggin REFERRED to the Committee on INSURANCE AND FINANCIAL SERVICES
Ordered sent down forthwith for concurrence.
2/5/2015 House Bill REFERRED to the Committee on INSURANCE AND FINANCIAL SERVICES.
In concurrence. ORDERED SENT FORTHWITH.
5/21/2015 Senate Reports READ.
On motion by Senator WHITTEMORE of Somerset the Majority Ought to Pass as Amended Report ACCEPTED.
READ ONCE.
Committee Amendment “A” (S-104) READ and ADOPTED.
Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment “A” (S-104) Ordered sent down forthwith for concurrence.
5/26/2015 House Reports READ.
On motion of Representative BECK of Waterville TABLED pending ACCEPTANCE of Either Report.

Later today assigned.
5/26/2015 House Unfinished Business
5/27/2015 House Unfinished Business
5/28/2015 House Unfinished Business
5/29/2015 House Unfinished Business
6/1/2015 House Unfinished Business
6/2/2015 House Unfinished Business
6/3/2015 House Speaker laid before the House
On motion of Representative BECK of Waterville, the Majority Ought to Pass as Amended Report was ACCEPTED.
The Bill was READ ONCE.
Committee Amendment “A” (S-104) was READ and ADOPTED.
Under suspension of the rules, the Bill was given its SECOND READING without REFERENCE to the Committee on Bills in the Second Reading.
The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment “A” (S-104).
In concurrence. ORDERED SENT FORTHWITH.
6/8/2015 House PASSED TO BE ENACTED.
ROLL CALL NO. 168
(Yeas 94 – Nays 47 – Absent 10 – Excused 0)
Sent for concurrence. ORDERED SENT FORTHWITH.
6/9/2015 Senate On motion by Senator CUSHING of Penobscot Tabled until Later in Today’s Session, pending ENACTMENT , in concurrence.
6/10/2015 Senate Unfinished Business
6/11/2015 Senate Unfinished Business
6/12/2015 Senate Unfinished Business
6/15/2015 Senate Taken from the table by the President ProTem
PASSED TO BE ENACTED , in concurrence.
6/30/2015 Senate LD 289 In Senate, June 30, 2015, this Bill, having been returned by the Governor, together with objections to the same pursuant to the provisions of the Constitution of the State of Maine, after reconsideration, the Senate proceeded to vote on the question: “Shall this Bill become a law notwithstanding the objections of the Governor?” 12 In Favor and 23 Against, accordingly it was the vote of the Senate that the Bill not become law and the VETO was SUSTAINED.

Bill Text & Amendments

Important Note: The bill text below presents L.D. 289 as originally introduced. L.D. 289 was changed by the legislature through amendment. To understand the impact of this legislation in proper context, be sure to read adopted amendment text, available here: C-A (S-104) .

An Act To Amend the Health Plan Improvement Law Regarding Prescription Drug Step Therapy

Be it enacted by the People of the State of Maine as follows:

Sec. 1. 24-A MRSA 4304, sub- 1-A is enacted to read:

1-A. Prescription drug step therapy. The clinical review criteria used by a carrier in approving prescription drugs:

A. Must adhere to federal Food and Drug Administration prescription drug labeling; and
B. May not require failure on the same medication on more than one occasion for patients continuously enrolled in a health plan offered by the carrier.

Nothing in this subsection may be construed to prevent a health care practitioner from prescribing a medication for an off-label use or from prescribing a medication on more than one occasion when the health care practitioner determines it is medically appropriate.

A carrier that requires failure on one or more drugs as a condition of prior authorization for a nonpreferred drug may not collect a copayment greater than the lowest cost preferred drug copayment in the same drug class from an enrollee having satisfied the prior authorization requirements, as judged by the prescribing health care practitioner. Nothing in this subsection may be construed to prevent a carrier from collecting tiered copayments from enrollees not subject to the prior authorization requirements set forth in this subsection.

SUMMARY

This bill establishes certain standards for prescription drug step therapy policies under the health plan improvement law.

Patterns of Support

Pattern of Cosponsorship by Region:

Pattern of Cosponsorship by Gender:

Pattern of Cosponsorship by Party:

Pattern of Cosponsorship by Campaign Finance Classification:

Note: Maine Clean Elections Act (MCEA) Qualified candidates only accept a small dollar value of initial contributions early in their campaigns, pledge not to accept further campaign contributions from private sources, and receive public funding for their campaigns. MCEA Non-Qualified candidates choose not to obtain public funding and instead are free to accept campaign contributions from individuals, party committees, political action committees and business sources.


This information about LD 289 was last updated on 2016-05-12.
The Open Maine Politics website is in a beta release and results should not be taken as definitive. Please visit the official website of the Maine State Legislature for entirely verifiable information.

Share this page…Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedInShare on TumblrDigg thisShare on RedditEmail this to someonePrint this page

Be the first to comment on "Maine LD 289: An Act To Amend the Health Plan Improvement Law Regarding Prescription Drug Step Therapy"

Leave a comment

Democracy thrives on participation; please share your thoughts!
Your email address will not be published. Required fields are marked *

Your email address will not be published.


*